Europe

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study
Economic evaluation of cancer registration in Europe
Embryonal cancers in Europe
Epidemiology of glial and non-glial brain tumours in Europe
Epidemiology of rare cancers and inequalities in oncologic outcomes
Geographical variability in survival of European children with central nervous system tumours
Incidence and survival of rare urogenital cancers in Europe
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002
Incidence, survival and prevalence of myeloid malignancies in Europe
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
Rare cancers are not so rare: the rare cancer burden in Europe
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
Rare thoracic cancers, including peritoneum mesothelioma
Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: results of EUROCARE-5
Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5

Page 1 of 2

Start
Prev
1
2
Next
End

This website uses cookies to ensure you get the best experience. Learn more about it.